EQUIGASTRIN® Oral Paste


Gastric secretion inhibitor.

Indicated for the treatment and prevention of gastric ulcers in adult horses and foals.

Technical Specification

Species


Horses.

Description


Indicated for the treatment and prevention of gastric ulcers in adult horses and foals.

Dosage form


Oral paste.

Therapeutic action


Gastric secretion inhibitor.

Composition


Each 100 g of oral paste contains: 
Omeprazole .............................37.0 g
Excipients q.s.p. ........................100 g

Indications


Indicated for the treatment and prevention of gastric ulcers in adult horses and foals.

Mode of application


 

  • To administer the treatment dose, place the notch of the dispenser in the division corresponding to the body weight of the animal. The total content of the syringe will treat 1,000 Kg of weight at the rate of 4 mg of omeprazole /Kg of weight.  
  • To administer the maintenance or preventive dose, place the notch of the dispenser in the division corresponding to half the body weight of the animal. In this case the total content of the syringe will allow treatment of four 500kg animals at a rate of 2 mg of omeprazole /Kg de peso, or dose a 500 kg animal for four days.       

Route od administration and dosage


Administration way: Oral.

For the treatment of gastric ulcers:
Administer a dose of 4 mg / Kg of body weight, once a day, for 28 consecutive days, followed by an administration of 2 mg / Kg of weight, once a day for 28 days, to reduce the recurrence of gastric ulcers after the treatment. If there is a recurrence, it is recommended to treat again with 4 mg / Kg of weight for 28 days.

For the prevention of gastric ulcers:
Administer a dose of 2 mg / Kg of body weight, once a day, for 28 consecutive days.

Practical product dose for a 500 kg horse:

Treatment of gastric ulcers:

  • From day 1 to 28, administer ½ syringe, 1 time a day.
  • From the 29th to the 56th, administer ¼ of a syringe, 1 time a day.

Recurrence (for 28 days): administer ½ syringe 1 time a day.

Prevention of gastric ulcers (for 28 days): administer ¼ syringe 1 time a day.

Drug interactions


  • Omeprazole could decrease the hepatic clearance of Diazepam, Phenytoin, or Warfarin, so it is recommended not to apply together.
  • Omeprazole can reduce the absorption of Ketoconazole, Ampicillin esters and Iron salts.

Contraindications


Contraindications, Warnings and Special Precautions for use:

  • Keep out of the reach of children
  • Do not administer to horses with known hypersensitivity to Omeprazole.
  • Do not administer to pregnant or lactating females.
  • Not recommended for horses less than 4 weeks old or with a body weight less than 70 kg.

Special precautions for the operator


  • Do not eat, drink or smoke while handling the product
  • Wash your hands after handling the product.
  • Avoid contact of the product with the skin and eyes.

Adverse effects


Unwanted effects and adverse reactions:
Omeprazole is generally well tolerated. However, gastrointestinal distress may occur (anorexia, colic, nausea, vomiting, flatulence, diarrhea).

Guard period


Do not administer to horses which meat is intended for human consumption.

Observations


Precautions for Disposal of Unused Product or Waste Material:
Empty containers can be discarded as household waste, in their original container and tightly closed. Do not dispose of containers with product remains on the ground or water courses.
Contact the manufacturing company or companies specialized in waste disposal, to receive recommendations on the disposal of expired or unused products.

Conservation


Store at a temperature between 2 and 30 ° C, protected from light. Once the container is opened, use within 8 days and keep between 15 and 30ºC, protected from light. Discard the unused product after that period of time.

Condition of sale


To be supply only on veterinary prescription. 

Presentation


A box with 4 graduated syringes, with 10.82g each.

Prepared by


Drag Pharma Laboratory.

Records


Chile: Reg. SAG No. 1954
Uruguay: Reg. MGAP N° 2017A00422 

Countries where it is marketed


Imported in Uruguay by:
VIVAFIL S.A. RIO NEGRO 1107 Montevideo - Uruguay, TEL 29001112
grupotecnovet@gmail.com
Technical Director: DMTV Diego Cuadrado.

You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).

Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian